Medical Meetings

Medical and scientific conferences are an important forum for the presentation of data relating to our products and pipeline. Below are upcoming or recent meetings at which data related to Alkermes' products or product candidates are being presented.  

45th Annual Meeting of the European Association for the Study of Diabetes (EASD), September 29 - October 2, Vienna, Austria

• Poster Presentation #730, Sept. 30, 1:45-2:45 p.m. CEST
  “Exenatide Once Weekly Treatment Elicits Sustained Glycaemic Control and Weight Loss Over 2 Years” was presented by Michael Trautmann, M.D.
• Poster Presentation #739, Oct. 1, 12:45-1:45 p.m. CEST
  “DURATION-2: Exenatide Once Weekly Demonstrated Superior Glycemic Control and Weight Reduction Compared to Sitagliptin or Pioglitazone After 26 Weeks of Treatment” was presented by Carol Wysham, M.D.
• Poster Presentation #758, Oct. 2, 12:45-1:45 p.m. CEST
  “Exenatide Once Weekly Improved Cardiometabolic Risk Factors in Subjects with Type 2 Diabetes During One Year of Treatment” was presented by Richard Bergenstal, M.D.
• Abstract Presentation #745, Oct. 1, 12:45-1:45 p.m. CEST
  “DURATION 2: Weight-Related Quality of Life, Psychological Well-Being, and Satisfaction with Exenatide Once Weekly Compared to Sitagliptin or Pioglitazone After 26 Weeks of Treatment” was presented by Jennie Best, Ph.D.